2 results match your criteria: "MA and Harvard Medical School Boston[Affiliation]"
Naltrexone in bipolar disorder with depression: a double-blind, placebo-controlled study.
J Clin Psychopharmacol
December 2014
Frazier Research Institute McLean Hospital Belmont, MA and Harvard Medical School Boston, MA Harvard Medical School Boston, MA and Laboratory for Psychiatric Biostatistics McLean Hospital Belmont, MA Frazier Research Institute McLean Hospital Belmont, MA and Harvard Medical School Boston, MA.
Oral SAMe in persistent treatment-refractory bipolar depression: a double-blind, randomized clinical trial.
J Clin Psychopharmacol
June 2014
Frazier Research Institute McLean Hospital Belmont, MA and Harvard Medical School Boston, MA Frazier Research Institute McLean Hospital Belmont, MA and Harvard Medical School Boston, MA Harvard Medical School Boston, MA and Laboratory for Psychiatric Biostatistics McLean Hospital Belmont, MA Frazier Research Institute McLean Hospital Belmont, MA and Harvard Medical School Boston, MA.